FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease

doi:10.3748/wjg.v22.i36.8211

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 36

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10877)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

626

WORD

220

HTML

5597

Figures (1-4)

576

Tables (1-1)

221

Sum=7240

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1257

Download

2380

Sum=3637

Sep 28, 2016 (publication date) through Dec 12, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Sep 28, 2016; 22(36): 8211-8218
Published online Sep 28, 2016. doi: 10.3748/wjg.v22.i36.8211

Full Size Figure Download Figure

Figure 3 Impact of positive or negative fecal calprotectin result on colonoscopy occurrence. Reduction in colonoscopies planned as a result of the availability of the fecal calprotectin test. There was a significant reduction in colonoscopies planned (P < 0.001). FC: Fecal calprotectin.

Citation: Rosenfeld G, Greenup AJ, Round A, Takach O, Halparin L, Saadeddin A, Ho JK, Lee T, Enns R, Bressler B. FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease. World J Gastroenterol 2016; 22(36): 8211-8218
URL: https://www.wjgnet.com/1007-9327/full/v22/i36/8211.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i36.8211